Medical Affairs Co-Op

Medical Affairs Co-Op Employer Legend Biotech Location Somerset, New Jersey Start date Mar 24, 2026 categoriesView less categories Job Details Company Job Details Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide. Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma. Legend Biotech is seeking a Medical Affairs Co-Op as part of the Medical Affairs team based in Somerset, NJ. Role Overview The Medical Affairs Co-Op will support and execute key initiatives that advance the organization's scientific, clinical, and strategic objectives with a primary focus on real world evidence generation. This opportunity provides hands-on experience across the medical affairs spectrum, working collaboratively with cross-functional teams to ensure the highest standards of scientific integrity and medical excellence.

Co-Op Duration:

12 months Key Responsibilities Support and operationalize real-world evidence (RWE) generation planning and activities. Participate in key opinion leader (KOL) engagements to understand evidence needs and data gaps. Assist in medical content and resource development. Contribute to publication planning process. Support medical information functions, ensuring compliance with medical and regulatory standards. Ability to travel ~25%. Requirements Post-graduate PharmD, MD, DO, or PhD in a biosciences field. Strong foundation in clinical research, pharmacology, biomedical science, or related disciplines. Excellent written and verbal communication skills, with the ability to convey complex scientific information clearly and accurately. Strong analytical and critical-thinking skills; ability to interpret scientific data and clinical evidence. High level of professionalism, collaborative mindset, and scientific rigor. Ability to manage multiple projects simultaneously and meet deadlines in a fast-paced environment. Proficiency with common computer-based tools and platforms. Curiosity and a proactive learning mindset. Strong attention to detail and commitment to quality. Excellent interpersonal skills and ease in engaging with external and internal stakeholders.

Skills You'll Gain Medical Strategy & Evidence Generation:

Ability to support medical strategy development and contribute to RWE study design and evidence generation.

KOL Engagement & Insight Gathering:

Skills in identifying and engaging key opinion leaders and synthesizing external clinical insights.

Cross-Functional Collaboration & Project Management:

Experience working with clinical, regulatory, safety, and commercial teams; ability to manage timelines, workflows, and complex medical affairs projects. #Li-JK1 #Li-Contract Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech. EEO Statement It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances. Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company. For information related to our privacy notice, please review: Legend Biotech Privacy Notice. Company Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap. For two years, Legend Biotech, then known as the "Legend Project," operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies. In 2015, Legend's scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China. In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world.

CARVYKTI

™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022. Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies. Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies. Company info Location Somerset New Jersey United States